Active Pharmaceutical Ingredients Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Active Pharmaceutical Ingredients stocks.

Active Pharmaceutical Ingredients Stocks Recent News

Date Stock Title
Apr 25 NVS Why Big Pharma Is Following Novartis' Lead In A $25 Billion Market
Apr 25 PRGO Perrigo gets offer to sell its HRA Pharma rare diseases unit
Apr 25 PRGO Perrigo Receives Binding Offer to Divest its HRA Pharma Rare Diseases Business for up to €275 Million
Apr 24 VTRS Inflation Reduction Act: A Bullish Catalyst For Viatris Inc.
Apr 24 NVS Novartis bags paediatric FDA label expansion for Lutathera
Apr 24 NVS Novartis AG (NYSE:NVS) Q1 2024 Earnings Call Transcript
Apr 24 NVS Company News for Apr 24, 2024
Apr 24 NVS Novartis and Medicines for Malaria Venture announce positive efficacy and safety data for a novel treatment for babies <5 kg with malaria
Apr 23 NVS Why Novartis Stock Topped the Market on Tuesday
Apr 23 NVS FDA Approves Novartis' Lutathera As First Therapy For Pediatric Patients With Gastroenteropancreatic Neuroendocrine Tumors
Apr 23 NVS Novartis wins pediatric indication for Lutathera for rare cancer
Apr 23 NVS Novartis radioligand therapy Lutathera® FDA approved as first medicine specifically for pediatric patients with gastroenteropancreatic neuroendocrine tumors
Apr 23 NVS Top Midday Stories: Shares of GE, Novartis, Danaher and Philip Morris Up Post-Earnings; Pepsi Stock Down Post-Earnings; Apple iPhone China Sales Drop 19%; Trump Poised for Windfall From Media Company Stock
Apr 23 NVS Novartis AG (NVS) Q1 2024 Earnings Call Transcript
Apr 23 NVS Novartis Stock Jumps After Beating Expectations, Raising Guidance
Apr 23 NVS Novartis Ag (NVS) Q1 2024 Earnings Call Transcript
Apr 23 NVS Novartis raises full-year guidance on Q1 beat, drug sales
Apr 23 NVS How Novartis Rode Two Blockbuster Drugs To Its Beat And Raise, And Three-Day Sprint
Apr 23 NVS Novartis: Strong Start To The Year With Beat-And-Raise First Quarter Results
Apr 23 NVS Incyte (INCY) to Report Q1 Earnings: What's in the Cards?
Active Pharmaceutical Ingredients

An active ingredient (AI) is the ingredient in a pharmaceutical drug or pesticide that is biologically active. The similar terms active pharmaceutical ingredient (API) and bulk active are also used in medicine, and the term active substance may be used for natural products. Some medication products may contain more than one active ingredient. The traditional word for the API is pharmacon or pharmakon (from Greek: φάρμακον, adapted from pharmacos) which originally denoted a magical substance or drug.
The terms active constituent or active principle are often chosen when referring to the active substance of interest in a plant (such as salicylic acid in willow bark or arecoline in areca nuts), because the word ingredient in many minds connotes a sense of human agency (that is, something that a person combines with other substances), whereas the natural products present in plants were not added by any human agency but rather occurred naturally ("a plant doesn't have ingredients").
In contrast with the active ingredients, the inactive ingredients are usually called excipients in pharmaceutical contexts. The main excipient that serves as a medium for conveying the active ingredient is usually called the vehicle. Petrolatum and mineral oil are common vehicles.

Browse All Tags